Genome-Based Diagnostics Demonstrating Clinical Utility in Oncology: Workshop Summary (2013) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 75-80
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 75... ...
• To consider innovative, sustainable research collaborations for gen erating evidence of clinical utility that involve multiple stakeholders.
|
From page 76... ...
Lurie Comprehensive Cancer Center Northwestern University 9:35–10:05 A.M. Payer Perspectives Elaine Jeter Medical Director Palmetto GBA Lee Newcomer Senior Vice President, Oncology United HealthCare Corporation 10:05–10:20 A.M.
|
From page 77... ...
Evolution of Translational Omics: Lessons Learned and the Path Forward Debra Leonard Professor and Vice Chair, Department of Pathology and Laboratory Medicine; Director of the Clinical Laboratories Weill Cornell Medical Center
|
From page 78... ...
McShane Senior Mathematical Statistician Biometric Research Branch Division of Cancer Treatment and Diagnosis National Cancer Institute 1:35–1:55 P.M. Assessing Cost-Effectiveness for Oncology-Based Molecular Diagnostics Kathryn Phillips Professor of Health Economics and Health Services Research Director and Founder, University of California, San Francisco (UCSF)
|
From page 79... ...
Novel Partnership Strategies for Using Outcomes Data to Develop Clinical Utility Evidence Gabriela Lavezzari Director of Development, Diagnostics Express Scripts
|
From page 80... ...
Concluding Remarks Robert McCormack, Workshop Co-Chair Head of Technology Innovation and Strategy Veridex, LLC 5:30 P.M.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.